ArticleOncology and therapy2024

Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate?

Heidi Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.